国际医药卫生导报 ›› 2022, Vol. 28 ›› Issue (21): 2969-2973.DOI: 10.3760/cma.j.issn.1007-1245.2022.21.003
李明月1,2 李自如2 姚远2,3 袁军2
收稿日期:
2022-07-19
出版日期:
2022-11-01
发布日期:
2022-11-16
通讯作者:
袁军,Email:13947108585@139.com
基金资助:
Li Mingyue1,2, Li Ziru2, Yao Yuan2,3, Yuan Jun2
Received:
2022-07-19
Online:
2022-11-01
Published:
2022-11-16
Contact:
Yuan Jun, Email: 13947108585@139.com
Supported by:
摘要: 随着2015年5项随机对照临床试验陆续发表,血管内治疗已成为大动脉闭塞所致急性脑梗死患者优选治疗方案。有一部分患者尽管血管已经再通,但是其预后不良。笔者通过查阅相关资料,发现有很多因素可能会影响到血管再通的效果及预后。该文就从时间窗、高血糖、侧支循环、血压、取栓次数、美国国立卫生研究院卒中量表(NIHSS)评分等部分影响血管内治疗疗效的可能因素作一综述。
李明月 李自如 姚远 袁军. 急性缺血性卒中患者血管内治疗疗效的相关因素分析[J]. 国际医药卫生导报, 2022, 28(21): 2969-2973.
Li Mingyue, Li Ziru, Yao Yuan, Yuan Jun. Factors related to efficacy of endovascular therapy for patients with acute ischemic stroke[J]. International Medicine and Health Guidance News, 2022, 28(21): 2969-2973.
[1] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.DOI:10.3760/cma.j.issn.1006-7876.2015.04.002. [2] Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project[J]. Stroke, 2008,39(6):1668-1674. DOI: 10.1161/STROKEAHA.107.502807. [3] Xu AD, Wang YJ, Wang DZ, et al. Consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel[J]. CNS Neurosci Ther, 2013,19(8):543-548. DOI: 10.1111/cns.12126. [4] Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2013,44(3):870-947. DOI: 10.1161/STR.0b013e318284056a. [5] Levy EI, Siddiqui AH, Crumlish A, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke)[J]. Stroke, 2009,40(11):3552-3556. DOI: 10.1161/STROKEAHA.109.561274. [6] Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials[J]. Lancet, 2014,384(9958):1929-1935. DOI: 10.1016/S0140-6736(14)60584-5. [7] Asadi H, Dowling R, Yan B, et al. Advances in endovascular treatment of acute ischaemic stroke[J]. Intern Med J, 2015,45(8):798-805. DOI: 10.1111/imj.12652. [8] 周峰,施洪超,陆敏,等.静脉溶栓在急性前循环大血管闭塞性脑卒中血管内治疗中的作用[J].中华神经科杂志,2019,52(6):472-477.DOI:10.3760/cma.j.issn.1006-7876.2019.06.006. [9] Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials[J]. Lancet, 2016,387(10029):1723-1731. DOI: 10.1016/S0140-6736(16)00163-X. [10] Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med, 2015,372(24):2285-2295. DOI: 10.1056/NEJMoa1415061. [11] Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med, 2015,372(11):1009-1018. DOI: 10.1056/NEJMoa1414792. [12] Berkhemer OA, Fransen PS, Beumer D, et al. Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015 Jan 1;372(1):11-20. doi: 10.1056/NEJMoa1411587. [13] Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med, 2015,372(24):2296-2306. DOI: 10.1056/NEJMoa1503780. [14] Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med, 2015,372(11):1019-1030. DOI: 10.1056/NEJMoa1414905. [15] Albers GW, Lansberg MG, Brown S, et al. Assessment of optimal patient selection for endovascular thrombectomy beyond 6 hours after symptom onset: a pooled analysis of the AURORA database[J]. JAMA Neurol, 2021,78(9):1064-1071. DOI: 10.1001/jamaneurol.2021.2319. [16] Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants[J]. Lancet, 2011,378(9785):31-40. DOI: 10.1016/S0140-6736(11)60679-X. [17] Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030[J]. Diabetes Care, 2004,27(5):1047-1053. DOI: 10.2337/diacare.27.5.1047. [18] Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030[J]. Diabetes Res Clin Pract, 2010,87(1):4-14. DOI: 10.1016/j.diabres.2009.10.007. [19] Putaala J, Liebkind R, Gordin D, et al. Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis[J]. Neurology, 2011,76(21):1831-1837. DOI: 10.1212/WNL.0b013e31821cccc2. [20] Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview[J]. Stroke, 2001,32(10):2426-2432. DOI: 10.1161/hs1001.096194. [21] Zi W, Wang H, Yang D, et al. Clinical effectiveness and safety outcomes of endovascular treatment for acute anterior circulation ischemic stroke in China[J]. Cerebrovasc Dis, 2017,44(5-6):248-258. DOI: 10.1159/000478667. [22] Anderson RE, Tan WK, Martin HS, et al. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra[J]. Stroke, 1999,30(1):160-170. DOI: 10.1161/01.str.30.1.160. [23] Li PA, Shuaib A, Miyashita H, et al. Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia[J]. Stroke, 2000,31(1):183-192. DOI: 10.1161/01.str.31.1.183. [24] Kamada H, Yu F, Nito C, et al. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction[J]. Stroke, 2007,38(3):1044-1049. DOI: 10.1161/01.STR.0000258041.75739.cb. [25] Cannarsa GJ, Wessell AP, Chryssikos T, et al. Initial stress hyperglycemia is associated with malignant cerebral edema, hemorrhage, and poor functional outcome after mechanical thrombectomy[J]. Neurosurgery, 2022,90(1):66-71. DOI: 10.1227/NEU.0000000000001735. [26] Mishiro K, Imai T, Sugitani S, et al. Diabetes mellitus aggravates hemorrhagic transformation after ischemic stroke via mitochondrial defects leading to endothelial apoptosis[J]. PLoS One, 2014,9(8):e103818. DOI: 10.1371/journal.pone.0103818. [27] 皮成慧,王君,张荣举,等.颅内侧支循环对急性脑梗死患者预后影响的研究进展[J].中国脑血管病杂志,2018,15(4):212-215.DOI:10.3969/j.issn.1672-5921.2018.04.009. [28] Bang OY, Saver JL, Kim SJ, et al. Collateral flow predicts response to endovascular therapy for acute ischemic stroke[J]. Stroke, 2011,42(3):693-699. DOI: 10.1161/STROKEAHA.110.595256. [29] Xu Y, Guo S, Jiang H, et al. Collateral status and clinical outcomes after mechanical thrombectomy in patients with anterior circulation occlusion[J]. J Healthc Eng, 2022,2022:7796700. DOI: 10.1155/2022/7796700. [30] John S, Hazaa W, Uchino K, et al. Timeline of blood pressure changes after intra-arterial therapy for acute ischemic stroke based on recanalization status[J]. J Neurointerv Surg, 2017,9(5):455-458. DOI: 10.1136/neurintsurg-2016-012369. [31] Matusevicius M, Cooray C, Bottai M, et al. Blood pressure after endo-vascular thrombectomy: modeling for outcomes based on recanalization status[J]. Stroke, 2020,51:519-525. DOI: 10.1161/STROKEAHA.119.026914. [32] Venema E, Mulder MJHL, Roozenbeek B, et al. Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials[J]. BMJ, 2017,357:j1710. DOI: 10.1136/bmj.j1710. [33] Mulder MJHL, Ergezen S, Lingsma HF, et al. Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in MR CLEAN (multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in the Netherlands)[J]. Stroke, 2017,48(7):1869-1876. DOI: 10.1161/STROKEAHA.116.016225. [34] van den Berg SA, Uniken Venema SM, Mulder MJHL, et al. Admission blood pressure in relation to clinical outcomes and successful reperfusion after endovascular stroke treatment[J]. Stroke, 2020,51(11):3205-3214. DOI: 10.1161/STROKEAHA.120.029907. [35] Ding X, Xu C, Zhong W, et al. Association of maximal systolic blood pressure with poor outcome in patients with hyperattenuated lesions on immediate NCCT after mechanical thrombectomy[J]. J Neurointerv Surg, 2020,12(2):127-131. DOI: 10.1136/neurintsurg-2019-014846. [36] Oliveira-Filho J, Silva SC, Trabuco CC, et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset[J]. Neurology, 2003,61(8):1047-1051. DOI: 10.1212/01.wnl.0000092498.75010.57. [37] Mistry EA, Mistry AM, Nakawah MO, et al. Systolic Blood Pressure Within 24 Hours After Thrombectomy for Acute Ischemic Stroke Correlates With Outcome[J]. J Am Heart Assoc, 2017,6(5):e006167. DOI: 10.1161/JAHA. 117.006167. [38] Samuels N, van de Graaf RA, van den Berg CAL, et al. Blood pressure in the first 6 hours following endovascular treatment for ischemic stroke is associated with outcome[J]. Stroke, 2021,52(11):3514-3522. DOI: 10.1161/STROKEAHA.120.033657. [39] Hao Y, Yang D, Wang H, et al. Predictors for symptomatic intracranial hemorrhage after endovascular treatment of acute ischemic stroke[J]. Stroke, 2017,48(5):1203-1209. DOI: 10.1161/STROKEAHA.116.016368. [40] García-Tornel Á, Requena M, Rubiera M, et al. When to Stop[J]. Stroke, 2019,50(7):1781-1788. DOI: 10.1161/STROKEAHA.119.025088. [41] Linfante I, Starosciak AK, Walker GR, et al. Predictors of poor outcome despite recanalization: a multiple regression analysis of the NASA registry[J]. J Neurointerv Surg, 2016,8(3):224-229. DOI: 10.1136/neurintsurg- 2014-011525. [42] 栗艳茹,韩冰莎,赵敬河,等.电磁扰动系数对急性缺血性卒中机械开通术后出血转化的预测作用[J].中国脑血管病杂志,2020,17(1):6-10,25.DOI:10.3969/j.issn.1672- 5921.2020.01.003. [43] 张兵军,石乃华,时小利,等.急性缺血性脑卒中取栓术后发生颅内出血性转化的危险因素[J].心脑血管病防治,2019,19(5):429-431.DOI:10.3969/j.issn.1009- 816x. 2019.05.013. [44] Ge WQ, Chen J, Pan H, et al. Analysis of risk factors increased hemorrhagic transformation after acute ischemic stroke[J]. J Stroke Cerebrovasc Dis, 2018,27(12):3587-3590. DOI: 10.1016/j.jstrokecerebrovasdis. 2018.08.028. [45] Zhu F, Labreuche J, Haussen DC, et al. Hemorrhagic Transformation After Thrombectomy for Tandem Occlusions[J]. Stroke, 2019,50(2):516-519. DOI: 10.1161/STROKEAHA.118.023689. [46] Hendrix P, Melamed I, Collins M, et al. NIHSS 24 h after mechanical thrombectomy predicts 90-day functional outcome[J]. Clin Neuroradiol, 2022,32(2):401-406. DOI: 10.1007/s00062-021-01068-4. [47] Shi ZS, Liebeskind DS, Xiang B, et al. Predictors of functional dependence despite successful revascularization in large-vessel occlusion strokes[J]. Stroke, 2014,45(7):1977-1984. DOI: 10.1161/STROKEAHA. 114.005603. [48] Liu R, Li W, Li Y, et al. Total time of operation is a risk factor of stroke-associated pneumonia in acute ischemic stroke patients with intra-arterial treatment[J]. Medicine (Baltimore), 2016,95(29):e3958. DOI: 10.1097/MD.0000000000003958. [49] Khatri P, Wechsler LR, Broderick JP. Intracranial hemorrhage associated with revascularization therapies[J]. Stroke, 2007,38(2):431-40. DOI: 10.1161/01.STR.0000254524.23708.c9. [50] Linfante I, Walker GR, Castonguay AC, et al. Predictors of mortality in acute ischemic stroke intervention: analysis of the North American Solitaire Acute Stroke Registry[J]. Stroke, 2015,46(8):2305-2308. DOI: 10.1161/STROKEAHA. 115.009530. [51] 李艳,孙璐,李林娇,等.老年脑卒中照顾者的照顾能力与照顾负担的相关性研究[J].国际医药卫生导报,2020,26(18):2677-2680.DOI:10.3760/cma.j.issn.1007-1245.2020. 18.004. |
[1] | 马芬芳, 李小玲, 刘玉嫦, 黄艳琼. 妊娠期糖尿病产妇新生儿血糖变化的相关因素分析[J]. 国际医药卫生导报, 2022, 28(8): 1147-1149. |
[2] | 张文君, 李月明, 何诗琪, 梁淑鸿, 刘映雪, 吴怡玲, 龚业青. 半导体激光联合30%超分子水杨酸治疗痤疮的疗效和护理体会 [J]. 国际医药卫生导报, 2022, 28(7): 1013-1016. |
[3] | 张力峰, 苏泉心, 高生林, 鹿超, 岳闯, 吴兴宇, 毛卫江, 左立. 改良阴茎成形术治疗青少年男性常见外生殖器畸形的疗效分析[J]. 国际医药卫生导报, 2022, 28(6): 745-748. |
[4] | 李富云, 薛麦富. 甲泼尼龙和利多卡因治疗难治性突发性聋伴耳鸣的效果[J]. 国际医药卫生导报, 2022, 28(6): 780-783. |
[5] | 徐丽琴, 洪庆荣, 方圆. 曲普瑞林对特发性中枢性性早熟女童的临床疗效和对骨龄的影响[J]. 国际医药卫生导报, 2022, 28(6): 829-832. |
[6] | 薛如君, 叶瑞贤, 周欣, 张锡宝. 银屑病光疗的应用及疗效[J]. 国际医药卫生导报, 2022, 28(5): 598-602. |
[7] | 叶东明, 赖彩永, 伍国豪, 陈智慧, 钟晓健. 尿管管腔内置斑马导丝对导尿困难患者的治疗效果观察[J]. 国际医药卫生导报, 2022, 28(5): 712-714. |
[8] | 郭智华, 鲁培, 卢晓燕, 黄淑妍, 陈兴. 三七总皂甙对老年不稳定型心绞痛患者Th1/Th2细胞功能失衡的影响[J]. 国际医药卫生导报, 2022, 28(4): 532-536. |
[9] | 杜江涛 李扬 欧阳山丹 刘炳震 林珍. 替加环素联合头孢哌酮舒巴坦治疗ICU重度腹腔感染的效果[J]. 国际医药卫生导报, 2022, 28(21): 3077-3081. |
[10] | 慈明伟 柯娇娇 张宁月. 安罗替尼联合依托泊苷加顺铂治疗广泛期小细胞肺癌的临床观察[J]. 国际医药卫生导报, 2022, 28(20): 2937-2940. |
[11] | 吴洁 邓秀红 雷丽芳 周佳佳. 火龙罐综合灸疗法在颈椎病颈痛患者中的效果观察[J]. 国际医药卫生导报, 2022, 28(20): 2947-2950. |
[12] | 刘毓, 黎惠金, 宋麒麟, 叶聪, 朱群芳. “L”形切口治疗中青年闭合性跟骨骨折术后康复期患足慢性肿胀的相关因素分析[J]. 国际医药卫生导报, 2022, 28(2): 166-170. |
[13] | 潘春柳, 黄志华. ICU医用粘胶相关性皮肤损伤患者相关因素的meta分析[J]. 国际医药卫生导报, 2022, 28(2): 270-277. |
[14] | 周珊汕, 吴智丹. 急性肾功能衰竭患者的综合护理干预分析[J]. 国际医药卫生导报, 2022, 28(2): 278-280. |
[15] | 于超生 于锋 邓海燕 李军政 黄昌锦 李慧. 电针法、穴位注射法治疗突发性聋的临床疗效研究[J]. 国际医药卫生导报, 2022, 28(18): 2522-2527. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||